Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Morisset Valerie. Director active across 1 company, notably Eliem Therapeutics, Inc.. In total, 13 disclosures have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1.7m. History available since 10 March 2023. The latest transaction was disclosed on 19 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
10,201 shares@ US$7.093.9% of flowCommon StockSEC:0001415889-24-019946:0
50,000 shares@ US$7.2419.6% of flowCommon StockSEC:0001415889-24-019946:1
39,005 shares@ US$8.0717.0% of flowCommon StockSEC:0001415889-24-019946:2
30,000 shares@ US$7.9813.0% of flowCommon StockSEC:0001415889-24-019946:3
3,207 shares@ US$6.911.2% of flowCommon StockSEC:0001415889-24-019814:0
50,000 shares@ US$7.1319.3% of flowCommon StockSEC:0001415889-24-019706:0
50,000 shares@ US$7.0719.2% of flowCommon StockSEC:0001415889-24-019610:0
5,931 shares@ US$6.662.2% of flowCommon StockSEC:0001415889-24-019504:0
12,342 shares@ US$7.064.7% of flowCommon StockSEC:0001415889-24-019433:0
7,649 shares@ US$0.00020.0% of flowCommon StockSEC:0001415889-24-019147:0
17,847 shares@ US$0.00020.0% of flowCommon StockSEC:0001415889-24-010516:0
5,431 shares@ US$0.0020.0% of flowCommon StockSEC:0001415889-24-006211:0
255,219 shares@ US$0.0020.0% of flowCommon StockSEC:0001209191-23-018531:0